Sarepta Therapeutics
ON THE RECORD · 3 verbatim quotes · every quote source-verified
“a different dose and is manufactured using a different process,”
Sarepta Therapeutics · said 2025-07-18 · reported 2025-07-19
Sarepta highlighted manufacturing and dosage differences between its experimental therapy and Elevidys.
verbatim, matched to source
Associated Press
“no new or changed safety signals”
Sarepta Therapeutics · said 2025-07-18 · reported 2025-07-19
Sarepta stated that its review showed no safety changes for younger patients receiving its Duchenne therapy.
verbatim, matched to source
Associated Press
“We look forward to continued discussions and sharing of information with FDA,”
Sarepta Therapeutics · said 2025-07-18 · reported 2025-07-19
Sarepta expressed its intention to continue communicating with the FDA despite refusing to halt shipments.
verbatim, matched to source
Associated Press